Skip to main content
. 2021 Oct 15;9:685497. doi: 10.3389/fped.2021.685497

Table 3.

LC3 and P62 expression levels in peripheral blood lymphocytes of normal children (C), pre-treatment SEL (SLE), traditional treatment at the end of 6 months (A), sirolimus treatment at the end of 6 months (B) (x¯ ± s).

Group n LC3 relative expression p62 relative expression
Normal group 15 0.3686 686.0832 0.6005 005.0890
SLE 30 0.5175 175.0721 0.4965 965.0730
Traditional treatment group 28 0.5097 097.0911* 0.4942 942.0688*
Sirolimus group 28 0.6485 485.1314*# 0.4028 028.0765*#

Compared with SLE before treatment, *P < 0.05; Compared with the traditional treatment group, #P < 0.05.